$1.32
-0.11-7.99%
Last update: Nov 5, 2:57 PM
Femasys Inc (FEMY) Stock Price, Quote, News & History
FEMYNASDAQ
FDA clears modular PMA pathway for Femasys' FemBloc, an investigational non-surgical permanent birth control device for women in the US.
You can purchase shares of Femasys (NASDAQ:FEMY) through any online brokerage.
Other companies in Femasys’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Femasys has a consensus price target of $112.86.
The stock price for Femasys (NASDAQ: FEMY) is $1.325 last updated November 5, 2026 at 2:57 PM EST.
There are no upcoming dividends for Femasys.
Femasys does not have any upcoming earnings scheduled.
There is no upcoming split for Femasys.
Femasys is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally...
